Nettesheim Emily R, Rowe Ashley A, Yee Tiffany, Alshaikhsalama Ahmed, Cepica Tyler, Dutt Vijaya, Virani Samita S, Wickersham Glen, Mahajan Vinit B, Small Kent W, Wert Katherine J
Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, Texas, United States.
Molecular Surgery Laboratory, Byers Eye Institute, Department of Ophthalmology, Stanford University, Palo Alto, California, United States.
Invest Ophthalmol Vis Sci. 2025 Aug 1;66(11):38. doi: 10.1167/iovs.66.11.38.
Retinal degeneration is a common cause of blindness, but there is a gap in our understanding of the molecular mechanisms causing degeneration. Dysregulated PRDM13 has been linked to retinal dystrophy, indicating a role for PRDM13 in the retina. PRDM13 knockout studies have shown that PRDM13 specifies amacrine cell fates, but no studies have shown the phenotypic and mechanistic outcomes of its elevated activity in the retina.
We developed a mouse model to induce aberrant PRDM13 expression in a controlled, time-dependent manner. ERG and histological analyses were performed to determine whether elevated PRDM13 impacted the health and function of the retina. RNA sequencing of retinas with and without elevated PRDM13 defined transcriptional changes in response to PRDM13 activity. Differentially expressed genes were validated by quantitative PCR and western blot.
We found that elevated PRDM13 decreases photoreceptor function and survival. Depletion of elevated PRDM13 halted this degenerative phenotype and restored some photoreceptor function. We further uncovered that elevated PRDM13 alters the expression of markers for amacrine subpopulations. Transcriptomic profiling revealed that elevated PRDM13 deregulates genes involved in retinal development, phototransduction, and photoreceptor health. We found downregulation of Prdm1-a photoreceptor marker-and Nr2e3-a key regulator of photoreceptor specification also implicated in retinal dystrophies-as well as effects on NR2E3's direct and indirect targets.
These findings establish a critical role for PRDM13 in retinal health and provide a new model for elucidating the impact of PRDM13 on photoreceptor maturation, maintenance, and function during retinal development.
视网膜变性是导致失明的常见原因,但我们对其变性的分子机制的理解存在差距。PRDM13失调与视网膜营养不良有关,表明PRDM13在视网膜中发挥作用。PRDM13基因敲除研究表明,PRDM13决定无长突细胞命运,但尚无研究表明其在视网膜中活性升高的表型和机制结果。
我们开发了一种小鼠模型,以可控的、时间依赖性的方式诱导PRDM13异常表达。进行视网膜电图(ERG)和组织学分析,以确定PRDM13活性升高是否会影响视网膜的健康和功能。对PRDM13活性升高和未升高的视网膜进行RNA测序,以确定对PRDM13活性的转录变化。通过定量PCR和蛋白质免疫印迹法验证差异表达基因。
我们发现PRDM13活性升高会降低光感受器功能和存活率。降低升高的PRDM13水平可阻止这种退行性表型,并恢复一些光感受器功能。我们进一步发现,PRDM13活性升高会改变无长突细胞亚群标志物的表达。转录组分析表明,PRDM13活性升高会使参与视网膜发育、光转导和光感受器健康的基因失调。我们发现光感受器标志物Prdm1和光感受器特异性关键调节因子Nr2e3(也与视网膜营养不良有关)表达下调,以及对NR2E3的直接和间接靶标的影响。
这些发现确立了PRDM13在视网膜健康中的关键作用,并为阐明PRDM13在视网膜发育过程中对光感受器成熟、维持和功能的影响提供了一个新模型。